MedPath

GlaxoSmithKline

GlaxoSmithKline logo
🇬🇧United Kingdom
Ownership
Public
Established
1929-01-01
Employees
70.2K
Market Cap
$90B
Website
http://www.gsk.com
Introduction

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

BOTOX® Drug Use Investigation (Spasmodic Dysphonia)

Conditions
Dysphonia
Interventions
First Posted Date
2018-06-01
Last Posted Date
2021-10-07
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
400
Registration Number
NCT03543150
Locations
🇯🇵

GSK Investigational Site, Tokyo, Japan

A Bioequivalence Study of Two Nicotine Lozenges in Fasting Conditions in Healthy Smokers

Phase 1
Completed
Conditions
Tobacco Use Disorder
Interventions
First Posted Date
2018-05-30
Last Posted Date
2020-03-12
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
46
Registration Number
NCT03541044
Locations
🇺🇸

GSK Investigational Site, Lincoln, Nebraska, United States

A Study to Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy Adults

Phase 2
Completed
Conditions
Dysentery, Bacillary
Interventions
Drug: Placebo
Biological: S.sonnei vaccine
Biological: S. sonnei 53G challenge strain
First Posted Date
2018-05-17
Last Posted Date
2020-07-28
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
71
Registration Number
NCT03527173
Locations
🇺🇸

GSK Investigational Site, Cincinnati, Ohio, United States

A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Participants With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody

Phase 2
Completed
Conditions
Multiple Myeloma
Interventions
Drug: Belantamab mafodotin frozen liquid
Drug: Belantamab mafodotin lyophilized powder
First Posted Date
2018-05-16
Last Posted Date
2024-10-23
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
221
Registration Number
NCT03525678
Locations
🇬🇧

GSK Investigational Site, Sutton, United Kingdom

Effects of GSK2798745 on Alveolar Barrier Disruption in a Segmental Lipopolysaccharide (LPS) Challenge Model

Phase 1
Terminated
Conditions
Healthy Volunteers
Interventions
Drug: Placebo
Drug: Lipoplysaccharide from Escherichia Coli
Drug: Saline
First Posted Date
2018-04-27
Last Posted Date
2021-03-29
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
47
Registration Number
NCT03511105
Locations
🇩🇪

GSK Investigational Site, Hannover, Niedersachsen, Germany

Adelphi Primary Sjogren's Syndrome (pSS) Disease Specific Programme (DSP)

Completed
Conditions
Sjogren's Syndrome
Interventions
Other: PSC questionnaire
Other: Interview
Other: PRFs
First Posted Date
2018-04-18
Last Posted Date
2019-01-23
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
2223
Registration Number
NCT03501420
Locations
🇬🇧

Adelphi Real World Investigational Site, Cheshire, United Kingdom

A Study to Characterize Diclofenac's Plasma and Knee Exposure After Application of Diclofenac Gel to the Knee of Subjects With Osteoarthritis That Have a Scheduled Arthroplasty

Phase 1
Completed
Conditions
Pain
Interventions
First Posted Date
2018-04-13
Last Posted Date
2020-02-24
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
47
Registration Number
NCT03497039
Locations
🇬🇧

GSK Investigational Site, Leeds, United Kingdom

A Clinical Study to Evaluate the Efficacy of Three Dry Mouth Relief Products Versus Water

Not Applicable
Completed
Conditions
Xerostomia
Interventions
Other: Water
Device: Biotene Original Oral Rinse
Device: Biotene Moisturizing Mouth Spray
Device: Experimental Oralbalance Moisturizing Gel
First Posted Date
2018-04-11
Last Posted Date
2018-09-26
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
422
Registration Number
NCT03494985

A Sourcing Study to Collect Human Blood Samples From Healthy Adults

Phase 4
Completed
Conditions
Meningitis, Meningococcal
Interventions
Biological: Meningococcal Groups A, C, W and Y Conjugate Vaccine (MenACWY)
Biological: rMenB+OMV NZ vaccine
First Posted Date
2018-04-11
Last Posted Date
2023-07-17
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
1021
Registration Number
NCT03493919
Locations
🇩🇪

GSK Investigational Site, Wuerzburg, Bayern, Germany

Daprodustat Bioequivalence and Food Effect Study

Phase 1
Completed
Conditions
Anaemia
Interventions
First Posted Date
2018-04-10
Last Posted Date
2020-07-08
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
64
Registration Number
NCT03493386
Locations
🇯🇵

GSK Investigational Site, Fukuoka, Japan

© Copyright 2025. All Rights Reserved by MedPath